Results 121 to 130 of about 25,215 (206)

Rechallenge with First-Line Anti-Tubercular Therapy After Toxic Epidermal Necrolysis in an HIV-Positive Patient with Tubercular Pleural Effusion. [PDF]

Indian Dermatol Online J
Narula AS, Mathews J, Ashraf F, Khadanga S.   +3 more
europepmc   +1 more source

Predicting pyrazinamide resistance in Mycobacterium tuberculosis using a graph convolutional network. [PDF]

BMC Microbiol
Dissanayake D, Brunner V, Adlard D, Morrone JA, Fowler PW.   +4 more
europepmc   +1 more source

Cutaneous Tuberculosis Presenting as a Chronic Dermatologic Disorder. [PDF]

Case Rep Dermatol Med
Spina O, Fraimow H, Green J.
europepmc   +1 more source

Weekly pulmonary delivery of β-glucan-chitosan-poly(lactic co-glycolic) acid (β-C-P) nanoparticles with daily standard oral therapy achieves control of <i>Mycobacterium tuberculosis</i> in BALB/c mice. [PDF]

Antimicrob Agents Chemother
Kutscher HL, Tamblin M, Kenney P, Reynolds JL.   +3 more
europepmc   +1 more source

Tuberculous spondylodiscitis following intravesical Bacille Calmette-Guérin therapy: A case report and systematic literature review. [PDF]

Surg Neurol Int
Kazami K, Narikiyo M, Hirokawa Y, Miyazaki R, Ohashi S, Nagasaki H, Tsuboi Y, Matsuoka H.   +7 more
europepmc   +1 more source

Identification and drug resistance profiling of <i>Mycobacterium orygis</i> from an African elephant using whole-genome sequencing. [PDF]

Microbiol Spectr
Ghayas H, Ashraf J, Saeed N, Zaka S, Shafiq S, Farooqi J, Jabeen K, Rais A, Rizvi AI, Mustafa G, Qureshi SA, Askari Y, Salahuddin N, Ozer EA, Hasan R.   +14 more
europepmc   +1 more source

Drug-induced hyperuricemia: multi-pathway regulation, causative drugs, and individualized management strategies. [PDF]

Front Pharmacol
Xiong B, Duan C, Xu S, Xu S, Yang C, He D, Luo C.   +6 more
europepmc   +1 more source

First-line drug-resistant tuberculosis among children under 15 years in Ethiopia: insights from phenotypic and whole-genome sequencing approaches. [PDF]

BMC Infect Dis
Abebaw Y, Ayele A, Ghodousi A, Alemayehu DH, Gebremicael G, Diriba G, Seid G, Cabibbe AM, Abebe M, Sheth A, Argaw R, Abegaz WE.   +11 more
europepmc   +1 more source

Management of adverse events in TB care and active TB drug safety monitoring. [PDF]

Breathe (Sheff)
Ma'aruf SY, Sharma A, Fox S, Duarte R, Lange C, Tiberi S.   +5 more
europepmc   +1 more source

Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies. [PDF]

J Clin Tuberc Other Mycobact Dis
Timboe K, Jackson JB, Becker GL.
europepmc   +1 more source